News1

The Korea Marine Environment Management Corporation (KOEM) has won a top award in the 2026 Public Institution AI Innovation Challenge for its AI-powered autonomous surface robot, which identifies and collects marine litter in areas inaccessible to conventional vessels.

KAIST neuroscientist Jung Jae-seung has published his first book in eight years since the bestseller Twelve Steps, offering reflections on humanity, relationships and the future through 40 conversations about artificial intelligence and everyday life.

Visual design and content creation accounted for 7.2% of work-related messages from personal ChatGPT accounts in South Korea in the third quarter, more than double the 3.3% recorded a year earlier.

Xreal has launched its Android XR-powered Aura wired extended reality glasses in South Korea, with prices starting at approximately $1,127 and features including Google Gemini integration, Bose audio technology and support for immersive video.

Hyundai Motor is rolling out an over-the-air update for the new Grandeur that improves access to door locks, gear status information and voice-based AI features through its next-generation infotainment system, PLEOS Connect.

Hyundai Motor Group showcased a parking robot that retrieves cars in 3 minutes at a demonstration event in Siheung City.

Daewoo Group's AI health data firm, DaNaA Data, launched a service analyzing biological age, disease risk, and health check results.

Defining school locations alone won't solve local healthcare issues; deeper strategies are needed for effective solutions.

Adenz Life Sciences wins a global medical device competition, earning a prize of 175,000 USD.

Daewoong Pharmaceutical introduces an AI-based smart hospital model for monitoring, diagnosis, testing, and rehabilitation.

Seoul St. Mary's Hospital's Rheumatology Center held an international training program for foreign experts on October 27 and 26.

Samsung Biologics enhances its CDO business by reducing the development time for next-gen biopharmaceuticals from 13 to 9 months.

South Korean medical AI company Noul has signed a three-year supply agreement for its miLab CER cervical cancer diagnostic solution in Bosnia and Herzegovina, marking an expansion into the Balkans as it seeks to grow its European business.

Inventage Lab has applied to begin an Australian Phase 1 clinical trial of IVL3021, a long-acting semaglutide injection designed for monthly dosing, to assess its pharmacokinetics and safety and support potential global partnerships and licensing deals.